A randomized controlled trial of povidone-iodine application after skin closure for prevention of surgical site infection in emergency cesarean sectio

Not Applicable

Recruiting

• Conditions: Superficial and deep surgical site infections in emergency cesarean sections; Surgical site infection; Emergency cesarean section; Povidone- iodine

• Registration Number: TCTR20180310002
• Lead Sponsor: one

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2018-03-10
• Study Completion: 2019-01-28
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 352

Inclusion Criteria

Women undergoing emergency cesarean section and planning to have a postpartum follow-up visit at King Chulalongkorn Memorial Hopital

Exclusion Criteria

Chorioamnionitis
DM/GDM with poorly controlled blood sugar (perioperative BS >200 mg/dl)
Suspected povidone-iodine allergy
Preoperative infection that need antibiotics after surgery
Undergoing peripartum hysterectomy

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The incidence of surgical site infection (superficial and deep SSIs) 30 days after surgery CDC surgical site infection criteria

Secondary Outcome Measures

Name	Time	Method
Risk factors of surgical site infection in emergency cesarean section 30 days after surgery Logistic regression analysis,Adverse effects of povidone-iodine. 30 days after surgery Patients reported outcomes